BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 29267886)

  • 1. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.
    Labuhn M; Adams FF; Ng M; Knoess S; Schambach A; Charpentier EM; Schwarzer A; Mateo JL; Klusmann JH; Heckl D
    Nucleic Acids Res; 2018 Feb; 46(3):1375-1385. PubMed ID: 29267886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities.
    Clarke R; Terry AR; Pennington H; Hasty C; MacDougall MS; Regan M; Merrill BJ
    Mol Cell; 2021 Jan; 81(2):226-238.e5. PubMed ID: 33378644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile 3' Functionalization of CRISPR Single Guide RNA.
    Palumbo CM; Gutierrez-Bujari JM; O'Geen H; Segal DJ; Beal PA
    Chembiochem; 2020 Jun; 21(11):1633-1640. PubMed ID: 31943634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SgRNA Expression of CRIPSR-Cas9 System Based on MiRNA Polycistrons as a Versatile Tool to Manipulate Multiple and Tissue-Specific Genome Editing.
    Xie C; Chen YL; Wang DF; Wang YL; Zhang TP; Li H; Liang F; Zhao Y; Zhang GY
    Sci Rep; 2017 Jul; 7(1):5795. PubMed ID: 28724960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus.
    Yang H; Wu JJ; Tang T; Liu KD; Dai C
    Sci Rep; 2017 Aug; 7(1):7489. PubMed ID: 28790350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo.
    Moreno-Mateos MA; Vejnar CE; Beaudoin JD; Fernandez JP; Mis EK; Khokha MK; Giraldez AJ
    Nat Methods; 2015 Oct; 12(10):982-8. PubMed ID: 26322839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system.
    Liu X; Homma A; Sayadi J; Yang S; Ohashi J; Takumi T
    Sci Rep; 2016 Jan; 6():19675. PubMed ID: 26813419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
    Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
    Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
    Hiranniramol K; Chen Y; Liu W; Wang X
    Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPcut: A novel tool for designing optimal sgRNAs for CRISPR/Cas9 based experiments in human cells.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Genomics; 2019 Jul; 111(4):560-566. PubMed ID: 29605634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
    Liu L; Yin M; Wang M; Wang Y
    Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
    Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
    Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
    Zhang B; Zhou J; Li M; Wei Y; Wang J; Wang Y; Shi P; Li X; Huang Z; Tang H; Song Z
    Anal Bioanal Chem; 2021 Apr; 413(9):2447-2456. PubMed ID: 33661348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.